Literature DB >> 32603420

First report of emicizumab use in a female patient with severe hemophilia A.

Géraldine Verstraete1, Catherine Lambert1, Cedric Hermans1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32603420      PMCID： PMC7362350          DOI： 10.1182/bloodadvances.2020002364

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  13 in total

1.  A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.

Authors:  Guy Young; Ri Liesner; Tiffany Chang; Robert Sidonio; Johannes Oldenburg; Victor Jiménez-Yuste; Johnny Mahlangu; Rebecca Kruse-Jarres; Michael Wang; Marianne Uguen; Michelle Y Doral; Lilyan Y Wright; Christophe Schmitt; Gallia G Levy; Midori Shima; Maria Elisa Mancuso
Journal:  Blood       Date:  2019-12-12       Impact factor: 22.113

Review 2.  A Molecular Revolution in the Treatment of Hemophilia.

Authors:  John S S Butterfield; Kerry M Hege; Roland W Herzog; Radoslaw Kaczmarek
Journal:  Mol Ther       Date:  2019-11-13       Impact factor: 11.454

3.  Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative.

Authors:  Jill M Johnsen; Shelley N Fletcher; Haley Huston; Sarah Roberge; Beth K Martin; Martin Kircher; Neil C Josephson; Jay Shendure; Sarah Ruuska; Marion A Koerper; Jaime Morales; Glenn F Pierce; Diane J Aschman; Barbara A Konkle
Journal:  Blood Adv       Date:  2017-05-18

4.  Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.

Authors:  Johnny Mahlangu; Johannes Oldenburg; Ido Paz-Priel; Claude Negrier; Markus Niggli; M Elisa Mancuso; Christophe Schmitt; Victor Jiménez-Yuste; Christine Kempton; Christophe Dhalluin; Michael U Callaghan; Willem Bujan; Midori Shima; Joanne I Adamkewicz; Elina Asikanius; Gallia G Levy; Rebecca Kruse-Jarres
Journal:  N Engl J Med       Date:  2018-08-30       Impact factor: 91.245

Review 5.  Women with bleeding disorders.

Authors:  C Hermans; R Kulkarni
Journal:  Haemophilia       Date:  2018-05       Impact factor: 4.287

6.  Association between phenotype and genotype in carriers of haemophilia A.

Authors:  W Miesbach; S Alesci; C Geisen; J Oldenburg
Journal:  Haemophilia       Date:  2010-12-01       Impact factor: 4.287

Review 7.  Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens.

Authors:  Johannes Oldenburg
Journal:  Blood       Date:  2015-02-23       Impact factor: 22.113

8.  Emicizumab for the treatment of haemophilia A: a narrative review.

Authors:  Massimo Franchini; Giuseppe Marano; Ilaria Pati; Fabio Candura; Samantha Profili; Eva Veropalumbo; Francesca Masiello; Liviana Catalano; Vanessa Piccinini; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-05       Impact factor: 3.443

Review 9.  Past, present and future of hemophilia: a narrative review.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Orphanet J Rare Dis       Date:  2012-05-02       Impact factor: 4.123

Review 10.  IgG placental transfer in healthy and pathological pregnancies.

Authors:  Patricia Palmeira; Camila Quinello; Ana Lúcia Silveira-Lessa; Cláudia Augusta Zago; Magda Carneiro-Sampaio
Journal:  Clin Dev Immunol       Date:  2011-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.